231 related articles for article (PubMed ID: 22361692)
1. Plasma exchange versus intravenous immunoglobulin for myasthenia gravis crisis: an acute hospital cost comparison study.
Heatwole C; Johnson N; Holloway R; Noyes K
J Clin Neuromuscul Dis; 2011 Dec; 13(2):85-94. PubMed ID: 22361692
[TBL] [Abstract][Full Text] [Related]
2. Cost-minimization analysis comparing intravenous immunoglobulin with plasma exchange in the management of patients with myasthenia gravis.
Furlan JC; Barth D; Barnett C; Bril V
Muscle Nerve; 2016 Jun; 53(6):872-6. PubMed ID: 26521889
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2008 Jan; (1):CD002277. PubMed ID: 18254004
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka KV
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002277. PubMed ID: 23235588
[TBL] [Abstract][Full Text] [Related]
5. A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patients.
Alipour-Faz A; Shojaei M; Peyvandi H; Ramzi D; Oroei M; Ghadiri F; Peyvandi M
Acta Neurol Belg; 2017 Mar; 117(1):245-249. PubMed ID: 27530310
[TBL] [Abstract][Full Text] [Related]
6. IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic.
Dhawan PS; Goodman BP; Harper CM; Bosch PE; Hoffman-Snyder CR; Wellik KE; Wingerchuk DM; Demaerschalk BM
Neurologist; 2015 May; 19(5):145-8. PubMed ID: 25970838
[TBL] [Abstract][Full Text] [Related]
7. Economic Costs of Myasthenia Gravis: A Systematic Review.
Landfeldt E; Pogoryelova O; Sejersen T; Zethraeus N; Breiner A; Lochmüller H
Pharmacoeconomics; 2020 Jul; 38(7):715-728. PubMed ID: 32363541
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2006 Apr; (2):CD002277. PubMed ID: 16625559
[TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis or intravenous immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital.
Pittayanon R; Treeprasertsuk S; Phanthumchinda K
J Med Assoc Thai; 2009 Apr; 92(4):478-82. PubMed ID: 19374297
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of therapeutic options used for myasthenia gravis.
Mandawat A; Kaminski HJ; Cutter G; Katirji B; Alshekhlee A
Ann Neurol; 2010 Dec; 68(6):797-805. PubMed ID: 21061395
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2003; (2):CD002277. PubMed ID: 12804431
[TBL] [Abstract][Full Text] [Related]
12. IVIG and PLEX in the treatment of myasthenia gravis.
Bril V; Barnett-Tapia C; Barth D; Katzberg HD
Ann N Y Acad Sci; 2012 Dec; 1275():1-6. PubMed ID: 23278570
[TBL] [Abstract][Full Text] [Related]
13. Estimated cost of treating myasthenia gravis in an insured U.S. population.
Guptill JT; Sharma BK; Marano A; Soucy A; Krueger A; Sanders DB
Muscle Nerve; 2012 Mar; 45(3):363-6. PubMed ID: 22334170
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
Jensen P; Bril V
J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
[TBL] [Abstract][Full Text] [Related]
15. Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.
Mahalati K; Dawson RB; Collins JO; Mayer RF
J Clin Apher; 1999; 14(1):1-8. PubMed ID: 10355656
[TBL] [Abstract][Full Text] [Related]
16. [Respective indications of plasma exchange and high-dose immunoglobulins in polyradiculoneuritis and myasthenia gravis].
Raphaël JC; Annane D; Chevret S; Chillet P; Gajdos P
Presse Med; 1996 Oct; 25(31):1516-22. PubMed ID: 8958883
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin treatment versus plasma exchange in patients with chronic moderate to severe myasthenia gravis.
Rønager J; Ravnborg M; Hermansen I; Vorstrup S
Artif Organs; 2001 Dec; 25(12):967-73. PubMed ID: 11843764
[TBL] [Abstract][Full Text] [Related]
18. Effects of Plasma Exchange Combined with Immunoglobulin Therapy on Consciousness, Immune Function, and Prognosis in Patients with Myasthenia Gravis Crisis: A Prospective Randomized Test.
Peng X; Xie XB; Tan H; Zhang D; Jiang BT; Liu J; Li S; Chen YR; Xie TY
Comput Math Methods Med; 2022; 2022():7796833. PubMed ID: 35813442
[TBL] [Abstract][Full Text] [Related]
19. Comparison of IVIg and PLEX in patients with myasthenia gravis.
Barth D; Nabavi Nouri M; Ng E; Nwe P; Bril V
Neurology; 2011 Jun; 76(23):2017-23. PubMed ID: 21562253
[TBL] [Abstract][Full Text] [Related]
20. Plasma exchange versus intravenous immunoglobulin in AChR subtype myasthenic crisis: A prospective cohort study.
Wang Y; Huan X; Jiao K; Jiang Q; Goh LY; Shi J; Lv Z; Xi J; Song J; Yan C; Lin J; Zhu W; Zhu X; Zhou Z; Xia R; Luo S; Zhao C;
Clin Immunol; 2022 Aug; 241():109058. PubMed ID: 35690385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
